In these prospective follow–up cases, levels of serum CK-18-M30, FGF-21, IL-1Ra and PEDF were increased, while OPG decreased in cases in non-NASH stage (first biopsy) compared to NASH stage (second biopsy). This evidence concerns the gene SERPINF1 and metabolic dysfunction-associated steatohepatitis.